Deucrictibant XR Tablet

Deucrictibant · Pharvaris Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deucrictibant XR Tablet, covering 2026-02-25 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency [Phase 3]

See pricing